Showing results (41-50 of 108) with videos related to
Sort By:
Pageof 11
Neurosurgery|February 28, 2008
Use of human neural tissue for the generation of progenitorsJeffrey P Greenfield, Angel Ayuso-Sacido, Theodore H Schwartz, et al.Neurosurgery|December 25, 2004
Experimental traumatic brain injury modulates the survival, migration, and terminal phenotype of transplanted epidermal growth factor receptor-activated neural stem cellsJohn A Boockvar, Joost Schouten, Nicolas Royo, et al.Operative Neurosurgery (Hagerstown, Md.)|August 21, 2018
Lessons Learned Using a High-Definition 3-Dimensional Exoscope for Spinal SurgeryKevin Kwan, Julia R Schneider, Victor Du, et al.Neurosurgical Review|January 30, 2023
Evolution of flash visual evoked potentials to monitor visual pathway integrity during tumor resection: illustrative cases and literature reviewZachary T Olmsted, Justin W Silverstein, Evan H Einstein, et al.Journal of Neuro-Oncology|August 7, 2023
First in-human intrathecal delivery of bevacizumab for leptomeningeal spread from recurrent glioblastoma: rationale for a dose escalation trialMatthew Holdaway, Faina Ablyazova, Shayan Huda, et al.World Neurosurgery|March 17, 2017
Frameless and Maskless Stereotactic Navigation with a Skull-Mounted TrackerAndrew A Fanous, Timothy G White, Matthew B Hirsch, et al.Cancer Research|October 15, 2013
Glioblastoma stem cells are regulated by interleukin-8 signaling in a tumoral perivascular nicheDavid W Infanger, YouJin Cho, Brina S Lopez, et al.International Journal of Surgical Pathology|March 23, 2026
Pituitary Metastasis as the Initial Manifestation of an Undiagnosed Adenocarcinoma of Mullerian Origin: A Case Report and Literature ReviewAruuke Sulaimanova, Brianna Suffren, Iuliia Lakhina, et al.World Neurosurgery|March 13, 2012
Intra-arterial delivery of bevacizumab after blood-brain barrier disruption for the treatment of recurrent glioblastoma: progression-free survival and overall survivalJan-Karl Burkhardt, Howard Riina, Benjamin J Shin, et al.Journal of Neurosurgery. Pediatrics|August 6, 2021
Intraarterial delivery of bevacizumab and cetuximab utilizing blood-brain barrier disruption in children with high-grade glioma and diffuse intrinsic pontine glioma: results of a phase I trialHeather J McCrea, Jana Ivanidze, Ashley O'Connor, et al.Pageof 11